Plus Therapeutics Ownership | Who Owns Plus Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Plus Therapeutics Ownership Summary


Plus Therapeutics is owned by 10.78% institutional investors, 1.40% insiders, and 87.82% retail investors. Vanguard group is the largest institutional shareholder, holding 2.99% of PSTV shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.15% of its assets in Plus Therapeutics shares.

PSTV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPlus Therapeutics10.78%1.40%87.82%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.45M2.99%$989.63K
Altium capital management lp918.91K1.90%$628.26K
Geode capital management813.25K1.68%$556.02K
Ubs group623.87K1.29%$426.73K
Blackrock funding, inc. /de469.39K0.97%$320.92K
State street341.89K0.71%$233.75K
Northern trust265.49K0.55%$181.51K
Scientech research146.65K0.30%$100.27K
Mercer global advisors inc /adv28.47K0.06%$19.47K
Dagco25.88K0.05%$17.70K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Altium capital management lp918.91K100.00%$628.26K
Scientech research146.65K0.03%$100.27K
Dagco25.88K0.00%$17.70K
Two sigma securities11.08K0.00%$7.57K
Tower research capital llc (trc)3.52K0.00%$2.41K
Sbi securities3.35K0.00%$2.29K
Ubs group623.87K0.00%$426.73K
Kestra advisory services25.80K0.00%$17.64K
Advisor group133.00-$59.00
Barclays2.00-$1.00

Top Buyers

HolderShares% AssetsChange
Vanguard group1.45M-1.41M
Altium capital management lp918.91K100.00%918.91K
Geode capital management813.25K-762.07K
Ubs group623.87K0.00%536.24K
Blackrock funding, inc. /de469.39K-462.43K

Top Sellers

HolderShares% AssetsChange
Jane street group---117.45K
Hrt financial lp---102.06K
Virtu financial---40.03K
Goldman sachs group---26.75K
Ground swell capital---11.45K

New Positions

HolderShares% AssetsChangeValue
Altium capital management lp918.91K100.00%918.91K$628.26K
State street341.89K-341.89K$233.75K
Northern trust265.49K-265.49K$181.51K
Scientech research146.65K0.03%146.65K$100.27K
Mercer global advisors inc /adv28.47K-28.47K$19.47K

Sold Out

HolderChange
Jones financial companies lllp-26.00
Citigroup-146.00
Tradewinds capital management-200.00
Atlantic union bankshares-500.00
Ground swell capital-11.45K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252335.29%5,214,8311279.19%10159.96%2081.82%2-33.33%
Jun 30, 2025176.25%378,108-2.84%25.96%1110.00%350.00%
Mar 31, 20251660.00%389,160-42.62%64.99%10150.00%2-
Dec 31, 202410-678,1730.98%1115.74%4---100.00%
Sep 30, 202410-16.67%671,584-1.47%87.78%4-42.86%2-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr93.55K0.15%61.01K
Fidelity Extended Market Index83.69K0.08%48.98K
Fidelity Nasdaq Composite Index8.90K0.05%-
Spartan Extended Market Index Pool E741.000.01%218.00
SSgA U.S. Extended Market Index Class I663.000.01%-
NT Ext Eq Mkt Indx Fd DC Lend T4556.000.01%556.00
NT Ext Eq Mkt Indx Fd DC Lend T3556.000.01%556.00
Spartan Total Market Index Pool G8.78K0.01%5.91K
Fidelity Series Total Market Index8.28K0.01%-
Fidelity Total Market Index5.32K0.01%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 04, 2025Sims Andrew John Hugh MacIntyre Chief Financial OfficerBuy$10.20K
Aug 22, 2025Lenk Robert P-Buy$53.78K
Sep 13, 2024Hawkins Richard J-Buy$6.00K
Sep 12, 2024Hawkins Richard J-Buy$8.51K
Sep 11, 2024Petersen Greg-Buy$16.88K

Insider Transactions Trends


DateBuySell
2025 Q41-
2025 Q31-
2025 Q2--
2025 Q1--
2024 Q36-

PSTV Ownership FAQ


Who Owns Plus Therapeutics?

Plus Therapeutics shareholders are primarily institutional investors at 10.78%, followed by 1.40% insiders and 87.82% retail investors. The average institutional ownership in Plus Therapeutics's industry, Biotech Stocks , is 45.22%, which Plus Therapeutics falls below.

Who owns the most shares of Plus Therapeutics?

Plus Therapeutics’s largest shareholders are Vanguard group (1.45M shares, 2.99%), Altium capital management lp (918.91K shares, 1.90%), and Geode capital management (813.25K shares, 1.68%). Together, they hold 6.57% of Plus Therapeutics’s total shares outstanding.

Does Blackrock own Plus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Plus Therapeutics.

Who is Plus Therapeutics’s biggest shareholder by percentage of total assets invested?

Altium capital management lp is Plus Therapeutics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 918.91K Plus Therapeutics shares, valued at 628.26K$.

Who is the top mutual fund holder of Plus Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Plus Therapeutics shares, with 0.15% of its total shares outstanding invested in 93.55K Plus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools